Chrysalis works alongside inventors to bring new FDA-regulated products to market.

The Chrysalis 4-Phase Product Appraisal and Development Blueprint

Appraisal: Define the unmet therapeutic or diagnostic need, explain how your product addresses it, and analyze the market size and competition.
Evaluate Feasibility: Assess the intellectual property landscape, regulatory considerations with FDA and CMS, clinical background, and financial aspects.
Business Blueprint: Detail research and development plans, create financial projections, outline the value proposition, and develop a prototype, quality plan, and clinical strategy, if applicable.
Secure Funding and Plan for Launch: Prepare a compelling pitch deck summarizing the report and outlining the fundraising strategy, and map out the product development process leading to regulatory approval, patent issuance, commercialization, and launch.
Phase 1 icon

Phase 1: Appraisal

In this initial phase, the focus is on understanding the problem your product aims to solve. Clearly define the unmet therapeutic or diagnostic need in the market. This involves describing the current standard of care, its limitations, and how your product offers a superior solution.

Research and analyze the market size to estimate the potential patient population and revenue opportunity. Conduct a thorough competitive analysis to identify existing products, their strengths and weaknesses, and your product’s unique value proposition. Assess the intellectual property landscape to determine the patentability of your innovation and potential infringement risks.

Understand the regulatory landscape by researching FDA and CMS requirements relevant to your product type.

Gather clinical background information on relevant diseases, treatment options, and outcomes to support your product’s efficacy and safety claims.

Finally, assess the financial feasibility of developing and commercializing your product by considering research and development costs, manufacturing expenses, and potential pricing strategies.

Phase 2 icon

Phase 2: Evaluate Feasibility

This phase delves deeper into the practical aspects of bringing your product to market. 

Elaborate on the research and development considerations, including the technical challenges, timelines, and resource requirements.

Develop detailed financial projections, including revenue forecasts, cost estimates, and profit margins. Construct a comprehensive valuation model to assess the potential financial return on investment for potential investors or partners.

If applicable, create a prototype to demonstrate the product’s functionality and gather user feedback. Design a quality plan so the product meets regulatory standards and customer expectations.

For products requiring clinical trials, outline the clinical strategy, including study design, endpoints, and patient population. For products regulated by CMS, detail the specific reimbursement codes and coverage policies. Start formulating a fundraising strategy by identifying potential sources of capital, such as venture capital firms, angel investors, or government grants.

Phase 3 icon

Phase 3: Business Blueprint

With the feasibility assessment complete, this phase focuses on crafting a comprehensive product development and commercialization strategy. Refine the research and development plan, outlining specific milestones, timelines, and deliverables. Finalize the financial projections and valuation model to present a compelling investment opportunity. If not already done, create a prototype to showcase the product’s features and benefits. Develop a robust quality plan to ensure the product meets regulatory and industry standards. 

For products requiring clinical trials, finalize the clinical plan, including study design, endpoints, and patient population. Define the regulatory strategy, including the pathway to FDA or CMS approval. Develop a comprehensive marketing and sales plan to reach target customers and generate revenue. Initiate fundraising efforts by engaging with potential investors or partners and presenting the compelling pitch deck summarizing the report’s findings.

Phase 4 icon

Phase 4: Secure Funding and Plan for Launch

The final phase focuses on securing the necessary funding and preparing for the product launch. Work with outside parties to execute the fundraising strategy by engaging with potential investors, presenting the pitch deck, and negotiating investment terms.

Continue refining the product development plan, ensuring alignment with regulatory requirements and market feedback. Obtain regulatory approval from FDA or CMS as required. Secure patents to protect your intellectual property.

Assemble a skilled commercial team to lead marketing, sales, and distribution efforts. Launch the product into the market, monitor its performance, and gather customer feedback.

Continue raising funds as needed to support ongoing development, marketing, and expansion efforts. Regularly review and update the product strategy to adapt to market dynamics and optimize commercial success.